De novo lupus nephritis and belimumab

from The Rheumatology Podcast · host Oxford University Press

Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval of belimumab for use in LN, and implications for clinical practice.

Episode metadata supplied by the publisher feed · Published Jan 26, 2022

Embed this episode

Attribution link and audio player

What this episode covers

Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

De novo lupus nephritis and belimumab

0:00 14:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 14 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on January 26, 2022.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!